Form 4 for GH Guardant Health, Inc.
Accepted 2025-06-09 00:00:00 ET · period of report 2025-06-05 · accession 0001576280-25-000169 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-09 | 2025-06-05+ | GH | Talasaz AmirAli | Co-CEO, Dir | S - Sale | $50.08 | -119.3K | 2.07M | -5% | -$5.97M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-06 | S | D | 39,751 | $50.07 | 2,147,309 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2024. (F3) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-06-05 | S | D | 1,680 | $50.00 | 2,187,060 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2024. (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.04 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2025-06-09 | S | D | 77,853 | $50.09 | 2,069,456 | D | — | — | (F1) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2024. (F4) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.41 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |